Moreover, active peptides in autoimmune diseases such as [K6T]P8, a peptide able to inhibit the receptor of IL-15, and Cyclotide [T20K]kalata B1, an active peptide in multiple sclerosis able to block immune-competent cells proliferation, were described. Here, IL15 is linked to multiple sclerosis.